Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
CNBC, analyzing data for GLP-1 drugs (Ozempic, Wegovy, Mounjaro, Zepbound) found that 9 million prescriptions of them were written in Q4 of 2022
CLICK HERE TO KNOW: Registering a Pharmaceutical Company in India: How to Obtain CDSCO & Drug License Approvals Regulatory oversight and supply chain monitoring The rapid expansion of Indias GLP-1 drug market following semaglutides patent expiry has prompted regulators to significantly tighten oversight across the pharmaceutical supply chain
The flagship trial STEP-1 (published in NEJM , 2021) found a mean weight reduction of ~14.9% of body weight with semaglutide 2.4 mg vs ~2.4% with placebo over 68 weeks ( [12] )
Effect of tirzepatide on blood pressure and lipids: A metaanalysis of randomized controlled trials
